Systemic antihistamines--a common outside the guidelines therapeutic strategy in hand eczema management

J Eur Acad Dermatol Venereol. 2016 Jan;30(1):67-71. doi: 10.1111/jdv.13060. Epub 2015 Mar 2.

Abstract

Background: Hand eczema (HE) is the most common skin disease affecting hands. Although the current treatment guidelines do not recommend use of systemic antihistamines as routine therapy, they seem to be widely used by physicians handling with this problem.

Objective: The aim of the study was to investigate the attitude to prescribe systemic antihistamines in HE.

Material and methods: A 10-item questionnaire was distributed among physicians participating in regional dermatological conferences. 127 valid questionnaires were analysed.

Results: A total of 127 physicians participated in the survey. 124 (97.6%) responders prescribe antihistamines in HE and 16 (12.6%) subjects declared routine use of oral antihistamines in the HE management. Significantly more dermatologists than other specialists used antihistamines in the treatment of HE accompanying atopic dermatitis (77.8% vs. 54.5%, P < 0.01) and dermatologists significantly more commonly used antihistamines in HE due to their anti-inflammatory properties (40.3% vs. 20.0%, P = 0.02). Regarding the type of eczema, antihistamines were prescribed most frequently in acute allergic HE (n = 92, 72.4%) and in HE accompanying atopic dermatitis (n = 86, 67.7%).

Conclusions: Despite the lack of the large, randomized, controlled studies on the effectiveness of the systemic antihistamines in the treatment of HE, this type of therapy seems to be prevalently used among the physicians.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Cross-Sectional Studies
  • Eczema / drug therapy*
  • Female
  • Hand Dermatoses / drug therapy*
  • Histamine Antagonists / therapeutic use*
  • Humans
  • Male
  • Middle Aged
  • Off-Label Use
  • Poland
  • Practice Patterns, Physicians' / statistics & numerical data*
  • Surveys and Questionnaires

Substances

  • Histamine Antagonists